Saturday, July 25, 2026
RSS

Defense

Ondas Holdings Expands Portfolio with $875.8M Acquisition of DZYNE

Ondas Holdings is set to acquire DZYNE for $875.8M, marking a significant move in the defense sector.

By Tyler Brooks • July 6, 2026
Critical Minerals

Solstice's $14.5B Acquisition of Element Solutions: A Game-Changer in Critical Minerals

Solstice Advanced Materials confirms a $14.5B acquisition of Element Solutions, reshaping the critical minerals landscape.

Diana Kowalski • Jul 6
Pharmaceutical

Vera Therapeutics Sees Stock Surge Ahead of Critical FDA Decision on Atacicept

Vera Therapeutics' stock jumped ahead of a pivotal FDA decision on atacicept, snapping a three-session slide and signaling strong market sentiment.

Marcus Rivera • Jul 6
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Pharmaceutical

Prestige Consumer Healthcare's Successful LaCorium Acquisition and Debt Financing

Prestige Consumer Healthcare strengthens its portfolio with LaCorium acquisition and a $400M senior notes offering.

Sarah Chen • Jul 6, 2026
Pharmaceutical

Incyte's Strategic Acquisition of Vega Therapeutics Enhances Hematology Portfolio

Incyte's acquisition of Vega Therapeutics marks a significant strategic move to bolster its hematology portfolio and mar…

James McAllister • Jul 6, 2026
Tech

AXT Inc. Secures Multi-Year Supply Agreement: Implications for the Semiconductor Market

AXT Inc. inks a three-year deal with Coherent, signaling growth potential in the semiconductor market driven by AI deman…

Marcus Rivera • Jul 3, 2026
Pharmaceutical

AbbVie’s Skyrizi Gets FDA Green Light for Pediatrics: A Game Changer for Growth Investors

AbbVie (ABBV) stock rose 3.44% following FDA approval for Skyrizi's pediatric use, signaling potential revenue growth.

Sarah Chen • Jul 3, 2026
Pharmaceutical

CRISPR Therapeutics and Vertex Pharmaceuticals Gain FDA Approval: What It Means for Investors

CRISPR Therapeutics and Vertex Pharmaceuticals see significant market movement following FDA approval for pediatric gene…

James McAllister • Jul 3, 2026
Markets & Money

American Express and Chase Battle for Premium Cardholders: Insights for Investors

Amex and Chase compete for affluent consumers with expanded perks, indicating a shift in the financial services landscap…

Catherine Walsh • Jul 3, 2026
Energy

US Oil Companies Report Profit Surge Amid Political Tensions with Trump Administration

US oil companies see profit increases as political tensions rise; investors should watch for impacts on energy stocks.

Tyler Brooks • Jul 3, 2026
Critical Minerals

Critical Metals Corp. Confirms Acquisition of European Lithium: Strategic Implications for Investors

Critical Metals Corp. updates on its acquisition of European Lithium, emphasizing the strategic importance of lithium as…

Diana Kowalski • Jul 3, 2026
Defense

Lockheed Martin Eyes $3.5 Billion Acquisition of Ultra Maritime: What This Means for Investors

Lockheed Martin's potential $3.5 billion acquisition of Ultra Maritime could reshape its naval capabilities and impact i…

Marcus Rivera • Jul 3, 2026